Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. (Lancet, 2003)

(untitled) - Sever, P; Dahlöf, B; Poulter, N; Wedel, H; Beevers, G; Caulfield, M; Collins, R; Kjeldsen, SE; Kristinsson, A; McInnes, G; Mehlsen, J; Nieminen, M; et al.